Effect of Statin Use on Influenza Vaccine Effectiveness

December 11, 2016 at 4:51 pm

Journal of Infectious Diseases October 15, 2016 V.214 N.8 P.1150-1158

Huong Q. McLean, Brian D. W. Chow, Jeffrey J. VanWormer, Jennifer P. King, and Edward A. Belongia

Center for Clinical Epidemiology and Population Health, Marshfield Clinic Research Foundation, Wisconsin

Background

Recent studies suggest that statin use may reduce influenza vaccine effectiveness (VE), but laboratory-confirmed influenza was not assessed.

Methods

Patients ≥45 years old presenting with acute respiratory illness were prospectively enrolled during the 2004–2005 through 2014–2015 influenza seasons. Vaccination and statin use were extracted from electronic records. Respiratory samples were tested for influenza virus.

Results

The analysis included 3285 adults: 1217 statin nonusers (37%), 903 unvaccinated statin nonusers (27%), 847 vaccinated statin users (26%), and 318 unvaccinated statin users (10%). Statin use modified VE and the risk of influenza A(H3N2) virus infection (P = .002) but not 2009 pandemic influenza A(H1N1) virus (A[H1N1]pdm09) or influenza B virus infection (P = .2 and .4, respectively). VE against influenza A(H3N2) was 45% (95% confidence interval [CI], 27%–59%) among statin nonusers and −21% (95% CI, −84% to 20%) among statin users. Vaccinated statin users had significant protection against influenza A(H1N1)pdm09 (VE, 68%; 95% CI, 19%–87%) and influenza B (VE, 48%; 95% CI, 1%–73%). Statin use did not significantly modify VE when stratified by prior season vaccination. In validation analyses, the use of other cardiovascular medications did not modify influenza VE.

Conclusions

Statin use was associated with reduced VE against influenza A(H3N2) but not influenza A(H1N1)pdm09 or influenza B. Further research is needed to assess biologic plausibility and confirm these results.

PDF

http://jid.oxfordjournals.org/content/214/8/1150.full.pdf+html

 

Advertisements

Entry filed under: Infecciones respiratorias, Infecciones virales, Influenza, Inmunizaciones, REPORTS, Update.

Tetravalent Dengue Vaccine Reduces Symptomatic and Asymptomatic Dengue Virus Infections in Healthy Children and Adolescents Aged 2–16 Years in Asia and Latin America Editorial – The Shifting Paradigm of Care for Adults Living With HIV – Smoking Cessation for Longer Life


Calendar

December 2016
M T W T F S S
« Nov   Jan »
 1234
567891011
12131415161718
19202122232425
262728293031  

Most Recent Posts


%d bloggers like this: